| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/18/1992 | EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. |
| 03/18/1992 | EP0474787A1 A process for treating infertility and an agent for use in the process. |
| 03/18/1992 | EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
| 03/18/1992 | EP0474764A1 Method to treat rheumatoid arthritis |
| 03/18/1992 | EP0474676A1 Production of ibdv vp2 in highly immunogenic form |
| 03/18/1992 | EP0474645A1 Protein complex |
| 03/18/1992 | EP0319545B1 Animal growth promotant |
| 03/18/1992 | EP0303625B1 Polypeptide competitor for immunoglobulin e |
| 03/18/1992 | EP0216786B1 Purification, production and use of tumor necrosis factors |
| 03/18/1992 | EP0188573B1 Dietary supplement for minimizing effects of infection |
| 03/18/1992 | CA2091905A1 Fungicidally active compounds |
| 03/18/1992 | CA2091759A1 Method and composition for controlling proliferation of cells |
| 03/18/1992 | CA2051455A1 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/18/1992 | CA2050042A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/18/1992 | CA2049506A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/17/1992 | US5097019 Pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4 |
| 03/17/1992 | US5097018 Sequential heat treatment of blood-clotting factor products |
| 03/17/1992 | US5097013 Novel peptides possessing a macrophage chemotactic activity |
| 03/17/1992 | US5096886 Bacteriostats |
| 03/17/1992 | US5096885 Containing glycine, mannitol and a buffer; stabilization for freeze drying |
| 03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
| 03/17/1992 | US5096815 Generation and selection of novel dna-binding proteins and polypeptides |
| 03/17/1992 | US5096718 Preserving foods using metabolites of propionibacteria other than propionic acid |
| 03/17/1992 | US5096707 Flavone-8-acetic acid and interleukin-2 in a method of treating certain cancers |
| 03/17/1992 | US5096705 Used for antitumor or antiviral treatment or for treatment of immunosuppressive conditions |
| 03/17/1992 | US5096704 Administering antagonist to Interleukin-5 which is a nonhuman monoclonal antibody |
| 03/17/1992 | US5096703 Administering aminoguanidine or its salts; oral rinse, tooth paste |
| 03/17/1992 | CA1297635C Protein purification |
| 03/17/1992 | CA1297634C Anticoagulating substance and preparation process thereof |
| 03/17/1992 | CA1297633C Phenylalanine derivative and proteinase inhibitor |
| 03/17/1992 | CA1297632C Organic compounds and their pharmaceutical use |
| 03/17/1992 | CA1297631C Ureido renin inhibitors |
| 03/17/1992 | CA1297437C Process for the preparation of protease inhibitors |
| 03/17/1992 | CA1297407C Pharmaceutical which can be administered nasally, a process for it preparation, and its use |
| 03/15/1992 | WO1992005198A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 03/15/1992 | WO1992005188A1 Production of multimeric glycoproteins through chemical coupling |
| 03/15/1992 | WO1992004908A1 Drug containing cd14 |
| 03/15/1992 | CA2091266A1 Expression of macrophage inducible proteins (mips) in yeast cells |
| 03/15/1992 | CA2072626A1 Drug containing cd14 |
| 03/15/1992 | CA2068651A1 Production of multimeric glycoproteins through chemical coupling |
| 03/15/1992 | CA2050634A1 Use of branched chain amino acids to effect diaphragm contractility and fatigue |
| 03/14/1992 | CA2025282A1 Process for preparing collagen-based composition product produced thereby, and method of applying same |
| 03/13/1992 | WO1992004444A1 Methods for producing acyloxyacyl hydrolase |
| 03/13/1992 | WO1992004369A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2091459A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2091242A1 Methods for producing acyloxyacyl hydrolase |
| 03/13/1992 | CA2051157A1 Neurotrophic peptide derivatives |
| 03/12/1992 | WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | DE4028487A1 Interleukin inhibitors of cytokine synthesis - used to treat nerve inflammation, associated pain, spinal injury and slipped disc |
| 03/12/1992 | CA2091335A1 Antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | CA2051044A1 Cytostatic agent |
| 03/12/1992 | CA2048094A1 Methods of conjugating actinomycin d |
| 03/11/1992 | WO1992004040A1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
| 03/11/1992 | EP0474553A1 Actinonin derivatives |
| 03/11/1992 | EP0474506A1 Antimicrobial peptides |
| 03/11/1992 | EP0474456A2 Oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells |
| 03/11/1992 | EP0474453A2 Pharmaceutical composition comprising an active peptide or protein and a heat-labile enterotoxin B and its mucous use |
| 03/11/1992 | EP0474438A1 Method for preventing or treating cerebrovascular disease employing the ACE-inhibitor ceronapril |
| 03/11/1992 | EP0474414A1 High purity crystalline forms of peptides Arg-Lys-Asp and Arg-Lys-Asp-Val, process for preparing them and pharmaceutical compositions containing them |
| 03/11/1992 | EP0474282A1 Use of polysaccharides in preparations for wound treatment |
| 03/11/1992 | EP0474141A1 Peptide or its salts |
| 03/11/1992 | EP0474008A1 Amino acid derivatives |
| 03/11/1992 | EP0473993A2 Novel peptide derivatives and their pharmaceutical use |
| 03/11/1992 | EP0473936A1 Renin Inhibitors |
| 03/11/1992 | EP0473716A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 03/11/1992 | EP0473651A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas |
| 03/11/1992 | EP0436611A4 Compound and method for the retardation of collagen cross-linking |
| 03/11/1992 | EP0392006A4 Method of making a free-flowing spray-dried edible powder comprising an oil |
| 03/11/1992 | EP0200757B1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna |
| 03/10/1992 | US5095139 Fungicides |
| 03/10/1992 | US5095097 Diagnostics |
| 03/10/1992 | US5095096 Fused protein comprising lymphotoxin |
| 03/10/1992 | US5095095 Immunosuppressant factor protein capable of inhibiting T-cell mechanisms |
| 03/10/1992 | US5095027 Antiischemic |
| 03/10/1992 | US5095006 Renin inhibitors having all retro-inverted peptide bonds |
| 03/10/1992 | US5095005 For foods |
| 03/10/1992 | US5095004 Fluorine containing atrial natriuretic peptides |
| 03/10/1992 | US5095003 Cyclic peptides |
| 03/10/1992 | US5094953 Human tissue plasminogen activator variants |
| 03/10/1992 | US5094949 Side effect reduction |
| 03/10/1992 | US5094941 Monoclonal antibodies to PDGF |
| 03/10/1992 | CA1297050C Expression systems for over production of desired proteins |
| 03/10/1992 | CA1297011C Method of producing a factor viii (ahf) containing fraction |
| 03/10/1992 | CA1297010C Combination of t-pa and a prostaglandin |
| 03/10/1992 | CA1297009C Use of t-pa for the inhibition of damage to jeopardized tissue during reperfusion in a mammal |
| 03/10/1992 | CA1297008C Aqueous parenteral solution of tissue-plasminogen activator |
| 03/10/1992 | CA1297007C Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same |
| 03/10/1992 | CA1297006C Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
| 03/10/1992 | CA1297005C Pharmaceutical agent for the treatment of myelogenous leukemia |
| 03/10/1992 | CA1297004C Pharmaceutical agent for promoting the recovery of hemopoietic capacity |
| 03/10/1992 | CA1297003C Composition and method for treating animals |
| 03/10/1992 | CA1297002C Adoptive immunotherapy as a treatment modality in humans |
| 03/08/1992 | WO1992004371A1 Kininogenase inhibitors |
| 03/08/1992 | CA2090858A1 Kininogenase inhibitors |
| 03/07/1992 | WO1992004049A1 Inhibitor of lymphocyte response and immune-related disease |
| 03/07/1992 | CA2071896A1 Inhibitor of lymphocyte response and immune-related disease |
| 03/05/1992 | WO1992004463A1 Cd58-specific monoclonal antibodies and their use |
| 03/05/1992 | WO1992004031A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | WO1992004015A2 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992004014A2 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |